Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.
ImportFab is a well-established contract manufacturer, specializing in the manufacturing and packaging of semi-solid and liquid products for the pharmaceutical, cosmetic and nutraceutical market. With 30 years of experience, the company has a very strong customer base. ImportFab is accredited by Health Canada and the US FDA.
Headquartered in Italy, Labomar is a reliable partner with over twenty years experience offering its customers effective, quality, front-line solutions in the field of food supplements, medical devices, cosmetics, as well as foods for special medical purposes. Labomar is engaged in production on behalf of third parties, providing a complete service ranging from selection of the raw materials to delivery of the finished product. The heart and soul of its activity is the research and development department, guaranteeing constant innovation and quality.
Oaklins' team in Canada advised the seller, contacted over 100 potential buyers through its international teams and negotiated the terms of the transaction. Oaklins' team in Italy introduced Labomar and assisted throughout the process.
Sylvain Renzi
Founder, Enterprises ImportFab, Inc.
Talk to the deal team
Related deals
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn moreArmira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn moreTriscan has joined APA and Riverarch to accelerate growth in the European aftermarket
Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.
Learn more